BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22179484)

  • 1. Cell growth of BG-1 ovarian cancer cells is promoted by di-n-butyl phthalate and hexabromocyclododecane via upregulation of the cyclin D and cyclin-dependent kinase-4 genes.
    Park MA; Hwang KA; Lee HR; Yi BR; Jeung EB; Choi KC
    Mol Med Rep; 2012 Mar; 5(3):761-6. PubMed ID: 22179484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced growth of BG-1 ovarian cancer cells by 17β-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression.
    Kang NH; Hwang KA; Kim TH; Hyun SH; Jeung EB; Choi KC
    Mol Med Rep; 2012 Jul; 6(1):151-6. PubMed ID: 22552626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methoxychlor and triclosan stimulates ovarian cancer growth by regulating cell cycle- and apoptosis-related genes via an estrogen receptor-dependent pathway.
    Kim JY; Yi BR; Go RE; Hwang KA; Nam KH; Choi KC
    Environ Toxicol Pharmacol; 2014 May; 37(3):1264-74. PubMed ID: 24835555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis.
    Hall JM; Korach KS
    Mol Carcinog; 2013 Sep; 52(9):715-25. PubMed ID: 22549810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hexabromocyclododecane and 4-nonylphenol on the regulation of cell growth, apoptosis and migration in prostatic cancer cells.
    Kim SH; Nam KH; Hwang KA; Choi KC
    Toxicol In Vitro; 2016 Apr; 32():240-7. PubMed ID: 26804032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fenhexamid and cyprodinil on the expression of cell cycle- and metastasis-related genes via an estrogen receptor-dependent pathway in cellular and xenografted ovarian cancer models.
    Go RE; Kim CW; Choi KC
    Toxicol Appl Pharmacol; 2015 Nov; 289(1):48-57. PubMed ID: 26344002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression.
    Hwang KA; Kang NH; Yi BR; Lee HR; Park MA; Choi KC
    Int J Oncol; 2013 Feb; 42(2):733-40. PubMed ID: 23229410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the cell cycle and P13K/AKT/mTOR signaling pathway by phthalates in normal human breast cells.
    Chen FP; Chien MH; Lee CH
    Taiwan J Obstet Gynecol; 2023 May; 62(3):434-439. PubMed ID: 37188449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k.
    Hong EJ; Ji YK; Choi KC; Manabe N; Jeung EB
    J Reprod Dev; 2005 Apr; 51(2):253-63. PubMed ID: 15883486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of BG-1 Ovarian Cancer Cells Expressing Estrogen Receptors with Lambda-cyhalothrin and Cypermethrin Caused a Partial Estrogenicity Via an Estrogen Receptor-dependent Pathway.
    Kim CW; Go RE; Choi KC
    Toxicol Res; 2015 Dec; 31(4):331-7. PubMed ID: 26877835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models.
    Lee HR; Hwang KA; Choi KC
    Int J Oncol; 2014 Aug; 45(2):595-602. PubMed ID: 24858230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The no-observed-adverse-effect level of phthalates promotes proliferation and cell cycle progression in normal human breast cells.
    Chen FP; Chien MH; Lee CH
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):874-883. PubMed ID: 38008508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway.
    Lee HR; Hwang KA; Park MA; Yi BR; Jeung EB; Choi KC
    Int J Mol Med; 2012 May; 29(5):883-90. PubMed ID: 22307313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models.
    Park MA; Hwang KA; Lee HR; Yi BR; Jeung EB; Choi KC
    Toxicology; 2013 Mar; 305():41-8. PubMed ID: 23328252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
    Lin Z; Zhang X; Zhao F; Ru S
    Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1.
    Du Y; Shi X; Ma W; Wen P; Yu P; Wang X; Fang P; Chen A; Gao Z; Cui K
    Pharmacol Res; 2021 Jul; 169():105648. PubMed ID: 33965509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower concentrations of phthalates induce proliferation in human breast cancer cells.
    Chen FP; Chien MH
    Climacteric; 2014 Aug; 17(4):377-84. PubMed ID: 24228746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphenol A and nonylphenol have the potential to stimulate the migration of ovarian cancer cells by inducing epithelial-mesenchymal transition via an estrogen receptor dependent pathway.
    Kim YS; Hwang KA; Hyun SH; Nam KH; Lee CK; Choi KC
    Chem Res Toxicol; 2015 Apr; 28(4):662-71. PubMed ID: 25690688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based system.
    Ho PW; Tse ZH; Liu HF; Lu S; Ho JW; Kung MH; Ramsden DB; Ho SL
    PLoS One; 2013; 8(9):e74065. PubMed ID: 24040167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.